VIRGIN-PULSE
Sir Richard Branson has challenged business leaders to improve the critical state of the modern workforce. His call comes at a time when 87% of employees are disengaged and sedentary office culture is being linked to diseases such as diabetes and heart disease.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170308005155/en/
With the annual cost of disengagement at $550 billion in the U.S. alone, Sir Richard Branson will personally lead the shakeup, committing 100 days of his time to the Virgin Pulse Global Challenge.
The global wellbeing program – part of the Virgin Group Portfolio, whose members will also take part – sees companies in 185 countries sign employees up to a journey that transforms their health, wellbeing and engagement levels.
Sir Richard Branson is now urging business leaders, in companies large and small, to show the same commitment to their workforce.
“Excellent leaders believe their people come first,” he said. “The health and culture of teams should always be paramount. If you take care of your employees, they’ll take care of your business. That’s why I’m urging all of you: join me in the Global Challenge. Let’s walk the walk!”
No stranger to healthy competition, or throwing his weight behind a cause, Sir Richard Branson has already prepared for the challenge and is issuing a video inviting others to join him .
Virgin Pulse CEO Chris Boyce welcomed Sir Richard Branson and Virgin Group’s involvement.
“We’re thrilled that Sir Richard Branson and our Virgin Group colleagues around the world are taking an active role in supporting global health in the workplace by participating in this year’s Virgin Pulse Global Challenge,” said Chris Boyce.
“Wellbeing is a critical business imperative, with organisations recognising the massive impact that physical, mental and social wellbeing have on employee engagement and business performance. Successful companies know that thriving businesses depend on thriving employees.
“Our mission at Virgin Pulse is to help organisations create thriving workplace cultures where employees are engaged, supported and empowered to bring their best selves to work, every day. We’re inviting business leaders everywhere to show their commitment to employee wellbeing by joining us in this year’s Global Challenge.”
The Virgin Pulse Global Challenge will kick off on May 24. For 100 days, Sir Richard Branson and over 400,000 members from 1,500 organisations in 185 countries across the globe will take a virtual journey that encourages physical activity, healthy eating, stress resilience, sleep quality and healthy habits. Together, members will form teams, set goals, and encourage each other to make healthy choices every day.
Learn how your organisation can join the Virgin Pulse Global Challenge at globalchallenge.virginpulse.com .
Part of Virgin Pulse’s suite of employee wellbeing and engagement solutions, Global Challenge is a turnkey event that fuses science and entertainment to engage employees, via a team-based virtual journey, in setting, tracking and achieving their health and wellbeing goals. This experience is extended through the company’s flagship solution, Virgin Pulse Engage , a fully integrated, daily employee engagement platform that builds on the Global Challenge to elevate culture, productivity and business performance by helping employees build and reinforce positive habits, at work and beyond.
About Virgin Pulse
Virgin
Pulse, the leading provider of technology solutions that promote
employee engagement and wellbeing and part of Sir Richard Branson’s
Virgin Group, helps employers create workforces that are happier,
healthier and ultimately more productive. The company’s modern,
mobile-first platform delivers a personalised user experience that
utilises gamification to engage users in building habits that inspire
meaningful and measurable change across individuals and the businesses
they serve.
By helping employees thrive at work and in all aspects of life, Virgin Pulse is helping change lives and businesses around the world for good. More than 2,200 global organisations representing many of the Fortune 500 and Best Places to Work, have selected Virgin Pulse’s solutions to engage their workforces and drive their businesses forward.
For more information about Virgin Pulse, visit: virginpulse.com .
For further information, please contact a media representative in your region.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170308005155/en/
Contact:
Virgin Pulse
Asia Pacific:
Emma Nguyen, +61 3 9536 8160
emma.nguyen@virginpulse.com
or
Andrea
Maltman, + 61 3 9536 8108
andrea.maltman@virginpulse.com
or
USA/Canada:
Elise
Meyer,+1 401-680-5920
elise.meyer@virginpulse.com
or
UK:
Charlotte
Church, +44 (0) 3304 30 30 43
charlotte.church@viginpulse.com
or
Europe:
Vicky
Kummer +41 (0) 44 723 10 77
vicky.kummer@virginpulse.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yokogawa Collaborates with Shell on Robotics and AI Technology for Plant Maintenance18.6.2025 08:00:00 CEST | Press release
- Streamlining operations and reducing risk in asset integrity management – Yokogawa Electric Corporation (TOKYO: 6841) announces that it has formalized a long-term agreement with Shell Global Solutions International B.V. (“Shell”) to integrate and further develop technologies for utilizing robots and drones in plant monitoring and maintenance. Under the agreement, Yokogawa will add an advanced machine vision tool called Operator Round by Exception (ORE), developed by Shell, into its own OpreX™ Robot Management Core. The enhanced software service will be made available by Yokogawa to customers in the energy, chemicals, and other industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617976629/en/ OpreX Robot Management Core ORE is a digital solution that uses machine vision and AI analytics to enable robots to autonomously perform a number of tasks in the operator round process, such as reading gauges and checking for
Ververica Announces Partnership with Aiven - Empowering Leading Enterprises to Create Value from their Data in Real-Time18.6.2025 08:00:00 CEST | Press release
Ververica, the original creators of Apache Flink® and a leader in stream processing technology, today announced a new partnership with Aiven, the AI-ready open source cloud data platform. This partnership enables Aiven to provide Ververica’s Unified Streaming Data Platform to their customers, expanding access to enterprise-grade streaming data capabilities for data-driven businesses around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617806011/en/ Ververica Announces Partnership with Aiven - Empowering Leading Enterprises to Create Value from their Data in Real-Time Under the partnership, Aiven customers can now unlock enterprise-grade stream processing with Ververica’s powerful platform — allowing them to make decisions and take actions at speed with data from any source — plus expert support from the original creators of Apache Flink. “This partnership is about removing friction and delivering real business
ICD 2025: New data demonstrate Nemluvio®’s (nemolizumab) favorable safety profile and sustained and clinically meaningful improvements in symptoms of prurigo nodularis up to two years18.6.2025 07:00:00 CEST | Press release
An interim analysis of the OLYMPIA long-term extension study to be presented as a late-breaking abstract at the XIV International Congress of Dermatology (ICD) found that Nemluvio was well tolerated and associated with sustained and clinically meaningful improvements in the key signs and symptoms of prurigo nodularis, including both skin lesions and itch, up to two years1 Results build on data from OLYMPIA – the largest completed pivotal clinical program in prurigo nodularis and the only one assessing long-term safety and efficacy in prurigo nodularis1-3 This follows the presentation of data from the ARCADIA long-term extension study at the Revolutionizing Atopic Dermatitis (RAD) Conference earlier this month, which showed Nemluvio is well tolerated with sustained and increased improvements in efficacy outcomes in atopic dermatitis patients up to two years4 Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy o
LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials18.6.2025 06:30:00 CEST | Press release
Invivoscribe is happy to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM) has received approval from New York State (NYS) for the NPM1 MRD Assay. This approval comes just two months after gaining NYS approval for our FLT3 ITD MRD Assay. Together these tests represent a critical tool for patients with acute myeloid leukemia (AML), clinicians and pharmaceutical companies. This new approval underscores Invivoscribe’s ongoing commitment to providing the most accurate, standardized measurable residual disease (MRD) testing solutions worldwide. The NPM1 MRD Assay is a pivotal development in the fight against AML, offering an ultra-sensitive DNA sequencing method to accurately measure trace levels of residual leukemia cells in patients with the NPM1 mutation variants. NPM1 mutations are considered an ideal target for MRD assessment because they are present in ~30% of adult AML cases,1 stable over time,2 and, if present in blood at allele
DNP to Take Controlling-Stake in Laxton18.6.2025 03:30:00 CEST | Press release
Maximizing synergies to accelerate the global expansion of biometric info-driven government authentication and security business Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/ Products of Laxton DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom